Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Yuksel, Urun"'
Autor:
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kilickap
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Introduction The advances in immune checkpoint inhibitors (ICIs) were relatively slow in rare tumors. Therefore, we conducted a multi‐center study evaluating the efficacy of ICI monotherapy and the combination of ICIs with chemotherapy (CT
Externí odkaz:
https://doaj.org/article/0f697c742e7245d3a185d956a2ca5f1a
Autor:
Sabin Goktas Aydin, Engin Eren Kavak, Atakan Topcu, Ayberk Bayramgil, Fahri Akgul, Seda Kahraman, Musa Baris Aykan, Yunus Emre Altıntas, Kaan Helvaci, Yuksel Urun, Ahmet Bilici, Mesut Seker, Mehmet Ali Nahit Sendur, Omer Fatih Olmez, Ozgur Acikgoz, Irfan Cicin
Publikováno v:
Biomolecules & Biomedicine, Vol 23, Iss 6 (2023)
Regorafenib, an oral multikinase inhibitor, has improved survival in metastatic colorectal cancer (mCRC) patients who have progressed on standard therapies. Our study aimed to evaluate prognostic factors influencing regorafenib treatment and assess t
Externí odkaz:
https://doaj.org/article/307cb5703f46446fb0e16815e2f38f8b
Autor:
Shouki Bazarbashi, Abdullah Alsharm, Alaa Meshref, Hind Mrabti, Jawaher Ansari, Marwan Ghosn, Mohamed Abdulla, Yuksel Urun
Publikováno v:
Urology Annals, Vol 14, Iss 4, Pp 303-313 (2022)
Despite the reliance on Western guidelines for managing prostate cancer (PC), there are wide variations and gaps in treatment among developing countries such as the Middle East African (MEA) region. A multidisciplinary team of experts from the MEA re
Externí odkaz:
https://doaj.org/article/400a15a07b5e43b8bdfc3e7b29b13ce6
Autor:
Dilara Turan, Hatime Arzu Yasar, Ozge Bas Aksu, Elif Berna Koksoy, Gungor Utkan, Hakan Akbulut, Yuksel Urun
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 3, Pp 130-133 (2018)
Aim: To evaluate the factors associated with Deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) in cancer patients. Materials and Methods: A total of 237 cancer patients who underwent lower extremity venous Doppler Ultrasonography (USG) a
Externí odkaz:
https://doaj.org/article/13eec35349314d2db3fd05fb9c6f420c
Autor:
Muhammet Bekir Hacioglu, Bulent Erdogan, Murat Bardakcı, Efnan Algın, Burcu Gulbagcı, Ilhan Hacibekiroglu, Jamshid Hamdard, Omer Fatih Olmez, Hadi Akkus, Berna Oksuzoglu, Sema Sezgin Goksu, Shute Ailia Dae, Ahmet Taner Sumbul, Muzaffer Ugraklı, Mustafa Karaagac, Elif Sahin, Devrim Cabuk, Ozden Ozer, Tugba Yavuzsen, Rukiye Arıkan, Osman Köstek, Muhammed Mustafa Atcı, Abdullah Sakin, Adem Deligonul, Duygu Bayır, Murat Dincer, Oktay Unsal, Ozan Yazıcı, Esra Zeynelgil, Ahmet Gulmez, Hakan Harputluoglu, Cihan Erol, Mehmet Ali Nahit Sendur, Aydin Aytekin, Baran Akagunduz, Irem Oner, Ozlem Er, Bugra Oztosun, Mahmut Gumus, Fatih Selcuk Biricik, Musa Baris Aykan, Nuri Karadurmus, Ezgi Degerli, Nebi Serkan Demirci, Esma Turkmen, Teoman Şakalar, Saban Secmeler, Ozgur Tanrıverdi, Ali Alkan, Yasemin Kemal, Ibrahim Cil, Caglar Unal, Yakup Iriagaç, Ozkan Alan, Sevinc Balli, Yuksel Urun, Erkan Ozcan, Nazım Serdar Turhal, Irfan Cicin
Publikováno v:
Head & Neck.
Background: Most of the studies on salivary gland cancers are limited for various reasons such as being single-center, small number of patients, including only major or minor SGCs, or only including epidemiological data. Methods: A total of 37 medica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79529589697c134a903b09e8faaa6c1f
https://doi.org/10.1002/hed.27376
https://doi.org/10.1002/hed.27376
Autor:
Izzet Dogan, Murat Ayhan, Mustafa Gurbuz, Ahmet Kucukarda, Esra Aydin, Yuksel Urun, Irfan Cicin, Pinar Saip
Publikováno v:
Medicine. 101(35)
Purpose: The study evaluated the distributions and prognostic significance of ABO and rhesus (D) groups in MBC patients.Patients and methods: The data of 137 patients were retrospectively reviewed. Clinical, histopathological data and ABO/Rh blood gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56a5412d3e0825fff944e6452d0dcf8
https://pubmed.ncbi.nlm.nih.gov/36107512
https://pubmed.ncbi.nlm.nih.gov/36107512
Publikováno v:
Üroonkoloji Bülteni, Vol 20, Iss 2, Pp 96-106 (2021)
Objective: The incidence of non-urothelial bladder cancers is very low, so our knowledge about their treatment protocols and prognosis is limited. We evaluated the clinicopathological characteristics of 26 patients in three different clinics and aime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b109f89952392f24609644713d555e
https://doaj.org/article/dd7fdcdf14b94d3586d8cbca02be46f4
https://doaj.org/article/dd7fdcdf14b94d3586d8cbca02be46f4
Autor:
Sabin Goktas Aydin, Burcin Cakan Demirel, Ahmet Bilici, Atakan Topcu, Musa Barış Aykan, Seda Kahraman, Ilgın Akbıyık, Muhammed Mustafa Atci, Omer Fatih Olmez, Arzu Yaren, Mehmet Ali Nahit Sendur, Caglayan Geredeli, Mesut Seker, Yuksel Urun, Nuri Karadurmus, Ahmet Aydin
Publikováno v:
Current medical research and opinion. 38(10)
Objectives: Advanced-stage biliary tract cancers (BTC) are rare malignancies with poor prognosis. There are few prospective trials, but several retrospective studies regarding treatment options. In this study, we aimed to investigate the role of syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c95409ebd82240f46af9a150505557
https://pubmed.ncbi.nlm.nih.gov/35916475
https://pubmed.ncbi.nlm.nih.gov/35916475
The benefit of treatment beyond progression with immune checkpoint inhibitors: A multi- center study
Autor:
Deniz Can Guven, Emre Yekeduz, Enes Erul, Sati Coskun Yazgan, Taha Koray Sahin, Gokturk Karatas, Sercan Aksoy, Mustafa Erman, Suayib Yalcin, Yuksel Urun, Saadettin Kilickap
Objective: Treatment beyond progression (TBP) with immune checkpoint inhibitors (ICIs) is an evolving field due to the limitations of conventional imaging in response evaluation with ICIs. However, real-life data on the benefit of TBP is scarce, espe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08fa59ad877b5fb9d28acf0513f09262
https://doi.org/10.21203/rs.3.rs-1867719/v1
https://doi.org/10.21203/rs.3.rs-1867719/v1
Autor:
Yuksel Urun, Mustafa Gürbüz
Publikováno v:
Üroonkoloji Bülteni, Vol 20, Iss 1, Pp 1-6 (2021)
Prostate cancer is the second most common cancer in men worldwide, with approximately 1,276,106 new patients and 358,989 new deaths. Metastatic castrationsensitive prostate cancer may be de novo metastatic, but also it may be in the localized disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9a4365ee3f716414f6c3604dcabc6ff
https://doi.org/10.4274/uob.galenos.2019.1407
https://doi.org/10.4274/uob.galenos.2019.1407